Stockreport

Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers [Yahoo! Finance]

AptarGroup, Inc.  (ATR) 
Last aptargroup, inc. earnings: 4/30 05:04 pm Check Earnings Report
US:NYSE Investor Relations: investors.aptar.com
PDF CRYSTAL LAKE, Ill., April 16, 2025 BUSINESS WIRE )--AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technol [Read more]